Centene backs FY24 adjusted EPS view of greater than $6.80

Speaking at 2024 Wells Fargo Healthcare Conference, Centene says, “Q3 is so far evolving thematically very similar to what you heard from us in Q2. We’re still on track for our adjusted EPS full year of greater than $6.80. We’re still seeing pressure in Medicaid…which continues to be offset by strong performance in our marketplace business.” Says it “feels really good” about its pricing strategy. FY24 EPS consensus at $6.85.